Physician profile
Patrick J Sweigert
NPI 1396109807
$10,618.18
in general payments reported to CMS, 2019-2025
13 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $451 · 2020: $23.25 · 2021: $1,279 · 2022: $895 · 2023: $231 · 2024: $7,315 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,626 · Food and Beverage: $1,344.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,626.25 |
| Food and Beverage | $1,343.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $7,000.24 | 2019-2024 | Stratafix, Harmonic, Linx Reflux Management System |
| Intuitive Surgical, INC. | $1,130.56 | 2021-2025 | |
| Davol INC. | $509.35 | 2022 | |
| Medtronic, INC. | $499.51 | 2023-2025 | Ligasure, Ta, Signia |
| W. L. Gore & Associates, INC. | $446.34 | 2019-2024 | Gore Enform Preperitoneal Biomaterial |
| Boston Scientific Corporation | $414.96 | 2024-2025 | Axios, Spyglass Discover |
| Allergan, INC. | $131.31 | 2019 | |
| Reshape Lifesciences INC. | $121.38 | 2023 | |
| Cook Medical LLC | $117.64 | 2021 | |
| Endolumik, INC. | $75.00 | 2025 | Endolumik Gastric Calibration Tube |
| Olympus America INC. | $67.13 | 2019 | |
| Medical Device Business Services, INC. | $63.09 | 2020-2024 | |
| Conmed Corporation | $41.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Sweigert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.